Detail
| LncRNA Name | H19 |
| Synonyms | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2 |
| Region | GRCh38_11:1995176-2001470 Sequence |
| Ensembl | ENSG00000130600 |
| RefSeq | NR_002196 |
| Circulating | ✘ |
| Drug-resisitant | ✔ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | cell line (KYSE31-R) |
| Expression Pattern | up-regulated |
| Function Description | We observed that three lncRNAs, MALAT1 , H19 , and CUDR , could be clinically useful as biomarkers for LC-MPE diagnosis. Moreover, the combination of MALAT2 and CEA provided higher sensitivity and accuracy in predicting LC-MPE than CEA alone. |
| Pubmed ID | 29731641 |
| Year | 2018 |
| Title | Combination of long noncoding RNA MALAT2 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. |
| External Links |
| Links for H19 | GenBank HGNC lncrnadb Noncode |
| Links for lung cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.